WASHINGTON — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers ...

Novo Suffers Wegovy Trial Setback as US Plans to Cut Price Patients lost 20.7% of body weight, disappointing investors US plan to target Wegovy in price negotiations hits shares ...

Your guide to what the 2024 US election means for Washington and the world Prices for Novo Nordisk’s blockbuster diabetes and weight-loss drugs Ozempic and Wegovy could face steep price cuts in ...

Novo Nordisk said that patients taking a higher dose of its blockbuster obesity drug Wegovy lost more weight than those on a lower dose without experiencing an increase in side-effects ...